AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer

Clinical trial NCT01597388 · COMPLETED

Trial details

NCT number: NCT01597388
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Metastatic Breast Cancer

Start date: 2012-05-08
Primary completion: 2016-08-04
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.